No Data
No Data
Grifols completed the sale of 20% of Shanghai RAAS Blood Products shares and reached a global strategy cooperation agreement with Haier Group.
With today's completed trade announcement, Grifols and Haier will collaborate through Shanghai RAAS to enhance China's medical care system. Through a stock purchase agreement, Grifols is selling 20% of Shanghai RAAS's shares to Haier Group for RMB 12.5 billion (approximately 1.6 billion euros). Grifols and Shanghai RAAS have extended their exclusive agent agreement for albumin for the next 10 years, and Shanghai RAAS can choose to extend it until 2044. All of Grifols' earnings will be used to fulfill its deleveraging commitments. Shanghai, June 18, 2024 / PR Newswire / - Global medical and health enterprises.
Eagle Capital Growth Fund Inc(GRF.US) Director Buys US$5,574 in Common Stock
$Eagle Capital Growth Fund Inc(GRF.US)$ Director Bilkie Robert M purchased 600 shares of common stock on May 17, 2024 at an average price of $9.29 for a total value of $5,574.Source: Announcement What
Eagle Capital Growth Fund Inc(GRF.US) Officer Sells US$45,950 in Common Stocks
$Eagle Capital Growth Fund Inc(GRF.US)$ Officer SIMS LUKE E sold 5,000 shares of Common Stocks on Feb 22, 2024 at an average price of $9.19 for a total value of $45,950.Source: Announcement What is st
Eagle Capital Growth Fund Inc(GRF.US) Officer Buys US$47,172.27 in Common Stocks
$Eagle Capital Growth Fund Inc(GRF.US)$ Officer Sims David C purchased 5,133 shares of Common Stocks on Feb 22, 2024 at an average price of $9.19 for a total value of $47,172.27.Source: Announcement W
Eagle Capital Growth Fund Inc To Go Ex-Dividend On November 22nd, 2023 With 0.35 USD Dividend Per Share
October 17th - $Eagle Capital Growth Fund Inc(GRF.US)$ is trading ex-dividend on November 22nd, 2023. Shareholders of record on November 24th, 2023 will receive 0.35 USD dividend per share on Dece
Eagle Capital Growth Fund, Inc. Dividend Declines by 5.4% to $0.35
No Data